Skip to main content
SpringerLink
Log in

Covalent and Noncovalent Protein Binding of Drugs: Implications for Hepatic Clearance, Storage, and Cell-Specific Drug Delivery

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

This review deals with the mechanisms by which the liver disposes of drugs that are covalently or noncovalently associated with proteins. Many drugs bind to plasma proteins such as albumin (mainly anionic compounds) and α1-acid glycoprotein (cationic compounds). Nevertheless, the liver is able to clear such drugs efficiently from the circulation because of intrahepatic dissociation of the drug-protein complex. This clearance may involve spontaneous dissociation because of progressive removal of the unbound drug during liver passage, a process that can be rate limiting in hepatic uptake. Alternatively, the porous endothelial lining of the hepatic sinusoids may allow extensive surface interactions of the drug–protein complexes with hepatocytes, leading to facilitation of drug dissociation. Binding to plasma proteins and intracellular proteins in the cytoplasm or cell organelles is an important factor determining the hepatic storage and elimination rate of drugs. Drugs noncovalently associated with glycosylated proteins, which can be endocytosed by various liver cells, are not co-endocytosed with such proteins. However, covalently bound drugs can be internalized by receptor-mediated endocytosis, which permits specific targeting to hepatocytes, endothelial cells, Kupffer cells, and lipocytes by coupling to different glycoproteins that are recognized on the basis of their terminal sugar. The endocytosed drug–carrier complex is routed into endosomes and lysosomes, where the active drug is liberated by cleavage of acid-sensitive linkages or proteolytic degradation of peptide linkers. This concept has been applied to antineoplastic, antiparasitic, and antiviral drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. J. L. Campra and T. B. Reynolds. In I. Arias, H. Popper, D. Schachter, and D. A. Shafritz (eds.), The Liver, Biology and Pathobiology, Raven Press, New York, 1982, pp. 627–645.

    Google Scholar 

  2. A. M. Rappaport, Z. J. Borowy, W. M. Lougheed, and W. N. Lotto. Anat. Rec. 119:11–27 (1954).

    Google Scholar 

  3. R. G. Thurman and F. C. Kauffman. Hepatology (Baltimore) 5:144–151 (1985).

    Google Scholar 

  4. K. Jungerman and N. Katz. Hepatology (Baltimore) 2:385–395 (1982).

    Google Scholar 

  5. J. J. Gumucio. Am. J. Physiol. 244:G578–G582 (1983).

    Google Scholar 

  6. G. M. M. Groothuis, M. J. Hardonk, K. K. Keulemans, P. Nieuwenhuis, and D. K. F. Meijer. Am. J. Physiol. 243:G455–G462 (1982).

    Google Scholar 

  7. I. Braakman, G. M. M. Groothuis, and D. K. F. Meijer. Hepatology 7:849–855 (1987).

    Google Scholar 

  8. E. R. Weibel, W. Staubli, H. R. Gragi, and F. A. Hess. J. Cell. Biol. 42:68–91 (1969).

    Google Scholar 

  9. A. Blouin, R. P. Bolender, and E. R. Weibel. J. Cell Biol. 72:441–455 (1977).

    Google Scholar 

  10. E. Wisse, R. de Zanger, and R. Jacobs. In D. L. Knook and E. Wisse (eds.), Sinusoidal Liver Cells, Elsevier, Amsterdam, 1982, pp. 61–67.

    Google Scholar 

  11. R. de Zanger and E. Wisse. In D. L. Knook and E. Wisse (eds.), Sinusoidal Liver Cells, Elsevier, Amsterdam, 1982, pp. 69–76.

    Google Scholar 

  12. P. Stahl and A. L. Schwartz. J. Clin. Invest. 77:657–662 (1986).

    Google Scholar 

  13. J. L. Goldstein, M. S. Brown, R. G. W. Anderson, D. W. Russell, and W. J. Schneider. Annu. Rev. Cell Biol. 1:1–39 (1985).

    Google Scholar 

  14. C. J. Steer and G. Ashwell. In H. Popper and F. Schaffner (eds.), Progress in Liver Diseases, Vol. 8, Grune and Stratton, New York, 1986, pp. 99–123.

    Google Scholar 

  15. A. L. Schwartz. C.R.C. Crit. Rev. Biochem. 16:207–223 (1984).

    Google Scholar 

  16. T. C. Wileman, C. Harding, and P. Stahl. Biochem. J. 232:1–14 (1985).

    Google Scholar 

  17. G. Ashwell and J. Harford. Annu. Rev. Biochem. 51:531–544 (1982).

    Google Scholar 

  18. H. J. Geuze, J. W. Slot, G. J. A. M. Strous, K. von Figura, A. Hasilik, and A. L. Schwartz. Cell (Cambridge) 37:195–204 (1984).

    Google Scholar 

  19. I. Mellman, R. Fuchs, and A. Helenius. Annu. Rev. Biochem. 55:663–700 (1986).

    Google Scholar 

  20. G. J. Schwartz and Q. Al-Awqati. Annu. Rev. Physiol. 48:153–161 (1986).

    Google Scholar 

  21. F. G. M. Russel, J. G. Weitering, R. Oosting, G. M. M. Groothuis, M. J. Hardonk, and D. K. F. Meijer. Gastroenterology 85:225–234 (1985).

    Google Scholar 

  22. R. R. Townsend, D. A. Wall, A. L. Hubbard, and Y. C. Lee. Proc. Natl. Acad. Sci. USA 81:466–470 (1984).

    Google Scholar 

  23. N. F. La Russo. Am. J. Physiol. 247:G199–G205 (1984).

    Google Scholar 

  24. P. van der Sluijs, I. Braakman, D. K. F. Meijer, and G. M. M. Groothuis. Hepatology 8:1521–1529 (1988).

    Google Scholar 

  25. S. Irie and M. Tavassoli. Biochem. Biophys. Res. Comm. 140:94–100 (1986).

    Google Scholar 

  26. M. Tavassoli, T. Kishimoto, and M. Kataoka. J. Cell Biol. 102:1298–1303 (1986).

    Google Scholar 

  27. T. F. Blaschke. Protein binding and kinetics of drugs in liver disease. Clin. Pharmacokinet. 2:32–44 (1977).

    Google Scholar 

  28. M. Rowland. Clin. Pharmacokin. 9:10–17 (1984).

    Google Scholar 

  29. K. M. Piafsky. Clin. Pharmacokinet. 5:24662 (1980).

    Google Scholar 

  30. Th. N. Tozer. In L. Z. Benet et al. (eds.), Pharmacokinetic Basis for Drug Treatment, Raven Press, New York, 1984, pp. 173–193.

    Google Scholar 

  31. D. K. F. Meijer, C. Neef, and G. M. M. Groothuis. In D. D. Breimer and P. Speiser (eds.), Topics in Pharmaceutical Sciences, Elsevier, Amsterdam, 1983, pp. 167–189.

    Google Scholar 

  32. D. K. F. Meijer. J. Hepatol. 4:259–268 (1987).

    Google Scholar 

  33. P. van der Sluijs and D. K. F. Meijer. J. Pharmacol. Exp. Ther. 234:703–707 (1985).

    Google Scholar 

  34. G. R. Wilkinson and D. G. Shand. Clin. Pharmacol. Ther. 18:377–390 (1975).

    Google Scholar 

  35. D. K. F. Meijer, R. J. Vonk, K. Keulemans, and J. G. Weitering. J. Pharmacol. Exp. Ther. 202:8–21 (1977).

    Google Scholar 

  36. D. K. F. Meijer, A. Blom, J. G. Weitering, and R. Hornsveld. J. Pharmacokinet. Biopharm. 12:43–65 (1984).

    Google Scholar 

  37. H. Grausz and R. Schmid. N. Engl. J. Med. 284:1403–1406 (1971).

    Google Scholar 

  38. M. Inoue. Hepatology (Baltimore) 5:892–898 (1985).

    Google Scholar 

  39. A. Blom, K. Keulemans, and D. K. F. Meijer. Biochem. Pharmacol. 30:1809–1816 (1981).

    Google Scholar 

  40. R. H. Levy and T. A. Moreland. Clin. Pharmacokinet. 9:1–9 (1984).

    Google Scholar 

  41. A. Blom, A. H. J. Scaf, and D. K. F. Meijer. Biochem. Pharmacol. 31:1553–1565 (1982).

    Google Scholar 

  42. E. L. Forker and B. A. Luxon. J. Clin. Invest. 67:1517–1522 (1981).

    Google Scholar 

  43. R. Weisiger, J. Gollan, and R. Ockner. Science 211:1048–1051 (1981).

    Google Scholar 

  44. R. K. Ockner, R. A. Weisiger, and J. L. Gollan. Am. J. Physiol. 245:G13–G18 (1983).

    Google Scholar 

  45. W. E. Muller and U. Wollert. Pharmacology 19:59–67 (1979).

    Google Scholar 

  46. K. J. Baker and S. E. Bradley. J. Clin. Invest. 45:281–287 (1966).

    Google Scholar 

  47. J. R. Bloomer, P. d. Berk, J. Vergalla, and N. I. Berlini. Clin. Sci. Mol. Med. 45:505–516 (1973).

    Google Scholar 

  48. E. L. Forker and B. A. Luxon. Hepatology 5:1236–1237 (1985).

    Google Scholar 

  49. S. C. Tsao, Y. Sugiyama, Y. Sawada, T. Iga, and M. Hanano. J. Pharmacokin. Biopharm. 16:165–181 (1988).

    Google Scholar 

  50. T. Horie, T. Mizuma, S. Kawai, and S. Awazu. Am. J. Physiol. 245:G465–G470 (1988).

    Google Scholar 

  51. W. Stremmel, B. J. Potter, and P. D. Berk. Biochim. Biophys. Acta 756:20–27 (1983).

    Google Scholar 

  52. U. Kragh Hansen. Pharmacol. Rev. 33:17–53 (1981).

    Google Scholar 

  53. D. J. Morgan, D. B. Jones, and R. A. Smallwood. Hepatology 5:1231–1235 (1985).

    Google Scholar 

  54. W. A. Colburn. J. Pharm. Sci. 71:373–374 (1982).

    Google Scholar 

  55. Y. R. Stollman, U. Gartner, L. Theilmann, N. Ohmi, and A. W. Wolkoff. J. Clin. Invest. 72:718–723 (1983).

    Google Scholar 

  56. R. A. Weisiger. Proc. Natl. Acad. Sci. USA 82:1563–1567 (1985).

    Google Scholar 

  57. L. Paul and C. P. Shorma. J. Cell Interface Sci. 84:546–549 (1981).

    Google Scholar 

  58. J. Wilting, W. F. van der Giesen, L. H. Janssen, M. Weideman, M. Otagiri, and J. K. Perrin. J. Biol. Chem. 255:3032–3037 (1980).

    Google Scholar 

  59. R. A. Weisiger and W. L. Ma. J. Clin. Invest. 79:1070–1077 (1987).

    Google Scholar 

  60. G. R. Wilkinson. Pharmacol. Rev. 39:1–47 (1987).

    Google Scholar 

  61. P. van der Sluijs, B. Postema, and D. K. F. Meijer. Hepatology 7:688–695 (1987).

    Google Scholar 

  62. W. B. Karp, M. Kinsley, S. B. Subramanyam, and A. F. Robertson. Alcohol Clin. Exp. Res. 9:429–432 (1985).

    Google Scholar 

  63. A. W. Wolkoff. Hepatology 7:777–779 (1987).

    Google Scholar 

  64. G. M. M. Groothuis, M. J. Hardonk, and D. K. F. Meijer. Trends Pharmacol. Sci. 6:322–327 (1985).

    Google Scholar 

  65. J. L. Barnhart, B. L. Witt, W. Hardison, and R. N. Berk. Am. J. Physiol. 244:G630–G636 (1983).

    Google Scholar 

  66. B. L. Blitzer and L. Lyons. Am. J. Physiol. 249:G34–G38 (1985).

    Google Scholar 

  67. S. Øie and F. Fiori. J. Pharmacol. Exp. Ther. 234:636–640 (1985).

    Google Scholar 

  68. J. H. Anderson, R. C. Anderson, and L. S. Iben. J. Pharmacol. Exp. Ther. 206:172–180 (1978).

    Google Scholar 

  69. M. S. Roberts and M. Rowland. J. Pharmacokinet. Biopharm. 14:261–289 (1986).

    Google Scholar 

  70. R. G. Murray and Y. K. Tam. Drug Metab. Disp. 15:27–31 (1987).

    Google Scholar 

  71. D. L. Eaton and J. A. Richards. Biochem. Pharmacol. 35:2721–2725 (1986).

    Google Scholar 

  72. Y. Echigoya, Y. Matsumoto, Y. Nakagawa, T. Suga, and S. Niinobe. Biochem. Pharmacol. 21:477–484 (1972).

    Google Scholar 

  73. J. W. Edmondson, B. A. Miller, and L. Lumeng. Am. J. Physiol. 249:G427–G433 (1985).

    Google Scholar 

  74. L. R. Engelkind, R. Gronwall, and M. S. Anwer. Am. J. Vet. Res. 41:355–361 (1980).

    Google Scholar 

  75. L. D. de Leve and K. M. Piafsky. Trends Pharmacol. Sci. 2:283–284 (1981).

    Google Scholar 

  76. M. Yashhara, J. Fujiwara, S. Kitade, H. Katayama, K. Okumara, and R. Hori. J. Pharmacol Exp. Ther. 235:513–520 (1985).

    Google Scholar 

  77. J. van Renswoude, K. R. Bridges, J. B. Harford, and R. D. Klausner. Proc. Natl. Acad. Sci. USA 79:6186–6190 (1982).

    Google Scholar 

  78. M. S. Brown and J. L. Goldstein. Science 232:34–47 (1986).

    Google Scholar 

  79. L. Robert, J. Migne, R. Santonja, R. Zini, K. Schmid, and J. P. Tillement. Int. J. Clin. Pharmacol. Ther. Toxicol. 21:271–276 (1983).

    Google Scholar 

  80. H. Karaskova, K. Bezouska, L. Starka, R. Hampl, A. T. Pikulev, M. V. Sholukh, and O. Taborski. J. Steroid Biochem. 24:725–729 (1986).

    Google Scholar 

  81. J. G. Weitering, W. Lammers, D. K. F. Meijer, and G. J. Mulder. Naunyn Schmiedeberg Arch. Pharmacol. 299:277–281 (1977).

    Google Scholar 

  82. Y. Echigoya, Y. Matsumoto, Y. Nakagawa, T. Suga, and S. Niinobe. Biochem. Pharmacol. 21:477–484 (1972).

    Google Scholar 

  83. P. van der Sluijs, H. H. Spanjer, and D. K. F. Meijer. J. Pharmacol. Exp. Ther. 240:668–673 (1987).

    Google Scholar 

  84. B. Ketterer, P. Ross-Mansell, and J. K. Whitehead. Biochem. J. 103:316–324 (1967).

    Google Scholar 

  85. A. J. Levi, Z. Gatmaitan, and I. M. Arias. J. Clin. Invest. 48:2156–2167 (1969).

    Google Scholar 

  86. K. S. Morey and G. Litwack. Biochem. J. 103:316–324 (1967).

    Google Scholar 

  87. C. D. Klaassen and J. B. Watkins. Pharmacol. Rev. 36:1–67 (1984).

    Google Scholar 

  88. N. M. Bass. Chem. Phys. Lipids 38:95–114 (1985).

    Google Scholar 

  89. B. Ketterer, E. Tipping, J. F. Hackney, and D. Beale. Biochem. J. 155:511–521 (1976).

    Google Scholar 

  90. E. L. Forker. Annu. Rev. Physiol. 39:323–347 (1977).

    Google Scholar 

  91. J. A. T. P. Meuwissen, B. Ketterer, and K. P. M. Heirwegh. In P. D. Berk and N. I. Berlin (eds.), Chemistry and Physiology of Bile Pigments, NIH, Bethesda, Md., 1977, pp. 323–327.

    Google Scholar 

  92. A. W. Wolkoff, C. A. Goresky, J. Sellin, Z. Gatmaitan, and I. M. Arias. Am. J. Physiol. 236:E638–E648 (1979).

    Google Scholar 

  93. D. K. F. Meijer, J. G. Weitering, and R. J. Vonk. J. Pharmacol. Exp. Ther. 198:229–239 (1976).

    Google Scholar 

  94. J. G. Weitering, G. J. Mulder, D. K. F. Meijer, W. Lammers, M. Veenhuis, and S. E. Wendelaar-Bonga. Naunyn-Schmiedeberg Arch. Pharmacol. 289:251–256 (1975).

    Google Scholar 

  95. P. Johansson, J. O. Josefsoon, and L. Nassbeyer. Br. J. Pharm. 83:615–623 (1984).

    Google Scholar 

  96. G. J. Kaloyanides. In C. Bianchi, A. Bertelli, and C. G. Duarte (eds.), Kidney, Small Proteins and Drugs, Contributions to Nephrology, Basel, Karger, 1984, pp. 148–167.

    Google Scholar 

  97. R. J. Fallon and A. L. Schwartz. Hepatology (Baltimore) 5:899–901 (1985).

    Google Scholar 

  98. M. J. Poznansky and R. L. Juliano. Pharmacol. Rev. 36:277–336 (1984).

    Google Scholar 

  99. R. A. Firestone, J. M. Pisano, M. M. McPhaul, and M. M. Krieger. J. Med. Chem. 27:1037–1043 (1984).

    Google Scholar 

  100. L. Fiume, A. Mattioli, P. G. Balboni, M. Tognon, B. Brodano, J. de Vries, and Th. Wieland. FEBS Lett. 103:47–51 (1979).

    Google Scholar 

  101. L. Fiume, A. Mattioli, C. Busi, and C. Accorsi. Gut 25:1392–1398 (1984).

    Google Scholar 

  102. J. Hofsteenge, A. Capuano, R. Altszuler, and S. Moore. J. Med. Chem. 29:1765–1769 (1986).

    Google Scholar 

  103. A. Trouet, P. Pirson, R. Baurain, and M. Masquelier. In W. Peters and W. H. G. Richards (eds.), Handbook of Experimental Pharmacology 68, Part 2, Springer Verlag, Berlin, 1984, pp. 253–266.

    Google Scholar 

  104. A. Trouet, M. Masquelier, R. Baurain, and D. Deprez de Campeneere. Proc. Natl. Acad. Sci. USA 79:626–629 (1982).

    Google Scholar 

  105. G. Y. Wu, C. H. Wu, and R. J. Stockert. Proc. Natl. Acad. Sci. USA 80:3078–3080 (1983).

    Google Scholar 

  106. D. L. Simpson, D. B. Cawley, and H. Herschmann. Cell (Cambridge) 29:469–473 (1982).

    Google Scholar 

  107. T. M. Chang and D. W. Killberg. J. Biol. Chem. 257:12563–12572 (1982).

    Google Scholar 

  108. G. Y. Wu, C. H. Wu, and M. I. Rubin. Hepatology (Baltimore) 5:709–713 (1985).

    Google Scholar 

  109. G. Y. Wu and C. H. Wu. Biochemistry 27:887–892 (1988).

    Google Scholar 

  110. L. Fiume, B. Bassi, C. Busi, A. Mattioli, G. Spinosa, and H. Faulstich. FEBS Lett. 203:203–206 (1986).

    Google Scholar 

  111. D. B. Cawley, D. L. Simpson, and H. R. Herschman. Proc. Natl. Acad. Sci. USA 78:3383–3387 (1981).

    Google Scholar 

  112. P. C. Smith and L. Z. Benet. Drug Metab. Disp. 14:503–505 (1986).

    Google Scholar 

  113. P. C. Smith, A. F. McDonagh, and L. Z. Benet. J. Clin. Invest. 77:934–939 (1986).

    Google Scholar 

  114. A. McDonagh, L. A. Palma, J. J. Lauff, and T. W. Wu. J. Clin. Invest. 74:763–764 (1984).

    Google Scholar 

  115. A. Gautam, H. Seligson, E. R. Gordon, D. Seligson, and J. L. Boyer. J. Clin. Invest. 73:873–877 (1984).

    Google Scholar 

  116. T. J. Mauch, T. M. Donohue, R. K. Zetterman, M. Sorrell, and D. J. Tuma. Hepatology (Baltimore) 6:263–269 (1986).

    Google Scholar 

  117. R. C. San George and H. D. Hoberman. J. Biol. Chem. 261:6811–6821 (1986).

    Google Scholar 

  118. H. F. Bunn, K. H. Gabbay, and P. M. Gallop. Science 200:21–27 (1978).

    Google Scholar 

  119. J. W. Baynes, S. R. Thorpe, and M. H. Martiashaw. Meth. Enzymol. 106:88–99 (1984).

    Google Scholar 

  120. N. Iberg and R. Fluckiger. J. Biol. Chem. 261:13542–13545 (1986).

    Google Scholar 

  121. S. Pongor, P. C. Ulrich, F. A. Benisath, and A. Cerami. Proc. Natl. Acad. Sci. USA 81:2684–2688 (1984).

    Google Scholar 

  122. J. L. Witztum, U. P. Steinbrecher, M. Fisher, and A. Kesaniemi. Proc. Natl. Acad. Sci. USA 80:2757–2761 (1983).

    Google Scholar 

  123. V. Vishwanath, K. E. Frank, C. A. Elmets, P. J. Dauchot, and V. M. Monnier. Diabetes 35:916–921 (1986).

    Google Scholar 

  124. V. Monnier, C. A. Elmets, and K. E. Frank. J. Clin. Invest. 78:832–835 (1986).

    Google Scholar 

  125. A. Cerami, H. Vlassara, and M. Brownlee. J. Cell. Biochem. 30:111–120 (1986).

    Google Scholar 

  126. H. Vlassara, M. Brownlee, and A. Cerami. Proc. Natl. Acad. Sci. USA 82:5588–5592 (1985).

    Google Scholar 

  127. H. Vlassara, M. Brownlee, and A. Cerami. J. Exp. Med. 164:1301–1309 (1986).

    Google Scholar 

  128. D. M. Mosser, H. Vlassara, P. J. Edelson, and A. Cerami. J. Exp. Med. 165:140–145 (1987).

    Google Scholar 

  129. J. C. Rogers and S. Kornfield. Biochem. Biophys. Res. Comm. 45:622–629 (1971).

    Google Scholar 

  130. G. Ashwell and C. J. Steer. JAMA 246:2358–2364 (1981).

    Google Scholar 

  131. L. Fiume, B. Bassi, C. Busi, A. Mattioli, and G. Spinosa. Biochem. Pharmacol. 35:967–972 (1986).

    Google Scholar 

  132. D. R. Vera, K. A. Krohn, R. C. Stadalnek, and P. O. Scheibe. Radiology 151:191–156 (1984).

    Google Scholar 

  133. R. C. Stadalnek, D. R. Vera, S. Woodle, W. L. Trudeau, B. A. Porker, R. E. Ward, K. H. Krohn, and L. F. O'Grady. J. Nucl. Med. 26:1233–1242 (1985).

    Google Scholar 

  134. H. J. M. Kempen, C. Hoes, J. H. v. d. Boom, H. H. Spanjer, J. de Lange, and A. Langendoen. J. Med. Chem. 27:1306–1312 (1984).

    Google Scholar 

  135. K. Furuno, N. Miwa, and K. Kabo. J. Biochem. 93:249–256 (1983).

    Google Scholar 

  136. P. van der Sluijs, R. Oosting, J. G. Weitering, M. J. Hardonk, and D. K. F. Meijer. Biochem. Pharmacol. 34:1399–1405 (1985).

    Google Scholar 

  137. S. Bose and J. Hickman. J. Biol. Chem. 252:8336–8337 (1977).

    Google Scholar 

  138. A. Rifai, D. S. Finbloom, D. Magilavy, and P. H. Plotz. J. Immunol. 128:2269–2275 (1982).

    Google Scholar 

  139. R. J. Stockert, H. B. Haimes, A. G. Morell, P. M. Novikoff, A. B. Novikoff, N. Quintana, and J. Sternlieb. Lab. Invest. 43:556–563 (1980).

    Google Scholar 

  140. J. Schmer, J. S. Holcenberg, and J. Roberts. Biochim. Biophys. Acta 538:397–405 (1978).

    Google Scholar 

  141. G. J. Murray, T. W. Doebber, T. Y. Shen, M. S. Wu, M. M. Poupipom, R. L. Bugianesi, R. O. Brady, and J. Barranger. Biochem. Med. 34:241–246 (1985).

    Google Scholar 

  142. F. S. Furbish, C. J. Steer, N. L. Krett, and J. A. Barranger. Biochim. Biophys. Acta 673:425–430 (1981).

    Google Scholar 

  143. V. Keegan-Rogers and G. Y. Wu. Hepatology 7:1026 (1987).

    Google Scholar 

  144. Th. J. C. van Berkel, D. J. Dekker, J. K. Kruyt, and H. G. van Eyk. Biochem. J. 243:715–722 (1987).

    Google Scholar 

  145. A. D. Attie, R. C. Pittman, and D. Steinberg. Proc. Natl. Acad. Sci. USA 77:5923–5927 (1980).

    Google Scholar 

  146. R. Duncan. In J. R. Robinson and V. H. L. Lee (eds.), Controlled Drug Delivery, Marcel Dekker, New York, 1986, pp. 582–607.

    Google Scholar 

  147. D. J. P. FitzGerald, T. A. Waldman, M. C. Willingham, and I. Pastan. J. Clin. Invest. 74:966–971 (1984).

    Google Scholar 

  148. W. C. Shen and H. J. P. Ryser. Biochem. Biophys. Res. Comm. 102:1048–1054 (1981).

    Google Scholar 

  149. E. S. Vitetta and J. W. Uhr. Annu. Rev. Immunol. 3:197–212 (1985).

    Google Scholar 

  150. P. van der Sluijs, H. P. Bootsma, B. Postema, F. Moolenaar, and D. K. F. Meijer. Hepatology 6:723–728 (1986).

    Google Scholar 

  151. L. Fiume, A. Mattioli, C. Busi, G. Spinosa, and Th. Wieland. Experientia 38:1087–1090 (1982).

    Google Scholar 

  152. W. M. Partridge, A. J. van Herle, R. T. Naruse, G. Fierer, and A. Costin. J. Biol. Chem. 258:990–994 (1983).

    Google Scholar 

  153. C. P. Stowell and Y. C. Lee. Adv. Carbohydr. Chem. Biochem. 37:225–281 (1980).

    Google Scholar 

  154. D. R. Vera, K. A. Krohn, R. C. Stadalnik, and P. O. Scheibe. J. Nucl. Med. 25:779–787 (1984).

    Google Scholar 

  155. D. T. Connolly, R. R. Townsend, and K. Kawaguchi. J. Biol. Chem. 257:939–945 (1982).

    Google Scholar 

  156. R. E. Pitas, J. Boyles, and R. W. Mahley. J. Cell Biol. 100:103–117 (1985).

    Google Scholar 

  157. J. F. Nagelkerke, K. P. Barto, and T. J. C. van Berkel. J. Biol. Chem. 258:12221–12227 (1983).

    Google Scholar 

  158. M. S. Brown and J. L. Goldstein. Annu. Rev. Biochem. 52:223–261 (1983).

    Google Scholar 

  159. M. E. Haberland and A. M. Fogelman. Proc. Natl. Acad. Sci. USA 82:2693–2697 (1985).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Therapeutics, University Center of Pharmacy, University of Groningen, Groningen, The Netherlands

    Dirk K. F. Meijer

  2. Department of Pharmacology and Therapeutics, University of Groningen, Ant. Deusinglaan 2, NL-9713, AW, Groningen, The Netherlands

    Dirk K. F. Meijer

  3. European Molecular Biology Laboratory, Heidelberg, F.R.G

    Peter van der Sluijs

Authors
  1. Dirk K. F. Meijer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter van der Sluijs
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meijer, D.K.F., van der Sluijs, P. Covalent and Noncovalent Protein Binding of Drugs: Implications for Hepatic Clearance, Storage, and Cell-Specific Drug Delivery. Pharm Res 6, 105–118 (1989). https://doi.org/10.1023/A:1015961424122

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015961424122

Search

Navigation